Travellers vaccinated with Covishield, manufactured by Pune-based Serum Institute of India (SII), may not be eligible for the European Union ‘Green Pass’, being launched to enable easy travel into and between EU countries.
The digital “vaccine passport” recognises the Vaxzevria version of the
vaccine that is produced in the UK and Europe, and approved by the European Medicines Agency (EMA). Covishield, manufactured by the Serum Institute of India, is not yet recognised by the EMA. 
Agencies
The EMA, which is the agency of the European Union responsible for the evaluation and supervision of medicinal products, has approved only four Covid-19 vaccines so far: Comirnaty (BioNTech-Pfizer), Moderna, Vaxzevria (Oxford-AstraZeneca) and Janssen (Johnson & Johnson). EU member states that issue the Green Pass must accept these four vaccines, but are free to accept others as well.
An email sent to EMA and SII did not elicit any response.
Iceland, France clarify rule
According to the website schengenvisainfo.com, Iceland, which was the first country in Europe to reopen borders for the vaccinated, clarified that only those who have received a vaccine authorised by EMA or the WHO would benefit from border reopening. It also reported that France, which has released a roadmap for opening its borders to travellers from the EU, the Schengen area and other countries, will also facilitate easy entry for those vaccinated with an EMA-approved vaccine, and not those being administered in Russia and India.
The Digital Covid Certificate, which will be launched on July 1, will allow holders to move freely within the European Union during the Covid-19 pandemic.
